step 1 trial semaglutide 2.4 mg weight loss nejm 2021 STEP-HFpEF Semaglutide Injection Protocol for Medical

5 Conclusions In summary, the GLP-1R/GCGR dual agonist TB001 effectively mitigates kidney allograft fibrosis and improves graft function, likely through mechanisms involving enhanced lipid metabolism and inhibition of the PKC-, PKC-, and TGF-1/SMAD2/3/Twist pathways

It can increase the risk of cancer, diabetes, hepatitis, and Parkinsons disease

When you use a semaglutide injection, it mimics the effects of GLP-1 in your body

Essentially, semaglutide helps you feel full longer and reduces your appetite by mimicking a hormone in your body that controls hunger

The researchers also took samples of skin and looked at them under the microscope

It can begin within days of the first injection, though it is often subtle at starting doses